PF4 and Thrombocytopenia: Another study by Liu et al. found that anti-PF4 titers correlated with COVID-19 disease severity scores as well as thrombocytopenia (96), albeit anti-PF4 antibodies observed in COVID-19 patients did not have the platelet-activating capability of anti-PF4 antibodies found in HIT or VITT.